Law Firm Investigates Four Companies Over Shareholder Deals

Law firm Halper Sadeh LLC has initiated investigations into four publicly traded companies: Destination XL Group, Inc. (DXLG), Standard BioTools Inc. (LAB), First Hawaiian, Inc. (FHB), and Rallybio Corporation (RLYB). The investigations concern the companies' planned transactions and potential violations of federal securities laws or breaches of fiduciary duty to shareholders.

The inquiry specifically focuses on Destination XL Group's merger with FBB Holdings I, Inc., Standard BioTools' combination with Treeline Biosciences, Inc., First Hawaiian's merger with TriCo Bancshares, and Rallybio's combination with Candid Therapeutics, Inc. The firm suspects that the transactions may include terms that could limit superior competing offers and that insiders may receive substantial financial benefits not available to ordinary shareholders.

Halper Sadeh LLC has encouraged shareholders of these companies to contact them to discuss their rights and options. The law firm stated it handles matters on a contingent fee basis, meaning shareholders would not be responsible for out-of-pocket legal fees or expenses. The firm has a history of representing investors and recovering millions of dollars for those who have fallen victim to securities fraud.

The investigations aim to determine if shareholders received fair terms in the proposed deals and, if necessary, to seek increased consideration, additional disclosures, or other benefits on behalf of the shareholders. No timeline for the completion of these investigations has been provided.